• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer

April 7, 2020 By admin Leave a Comment

Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease causing proteins, today announced the closing of a USD $7.5m Series A round, led by Advent Life Sciences. Seed round funders the Scottish Investment Bank, with backing from the Scottish Growth Scheme, and the European Investment Fund joined the round, along with new investor, US-based life sciences BioMotiv.

Amphista’s CEO Nicola Thompson said, “This international financing provides Amphista with a firm foundation to underpin a Series B round to progress our oncology pipeline to the clinic. Our vision is to create a leading protein degradation company on the global stage that delivers ground-breaking new medicines to patients in areas of high unmet need.”

Raj Parekh, General Partner at lead investor Advent Life Sciences said, “We are excited to support Amphista in its next stage of development. The Company has a potentially unique approach to targeted protein degradation when compared with traditional proteolysis targeting chimera (PROTAC®) platforms. We believe that Amphista has great potential with its differentiated proprietary technology to address traditionally undruggable targets.”

Satish Jindal, CEO of BioMotiv, and newly appointed Amphista Chairman, commented, “We are a mission-driven accelerator, and we are excited by Amphista’s focus to rapidly produce potent bifunctional small molecules to augment the body’s own processes to remove disease-associated proteins. We see huge potential to accelerate Amphista’s breakthrough technology platform into medicines.”

Amphista’s scientific founder, Professor Alessio Ciulli, based at the University of Dundee, is an internationally renowned expert in the field of targeted protein degradation (TPD). “Highly specific TPD is a transformative new modality for tackling previously undruggable targets with high therapeutic value,” said Ciulli.

Amphista’s TPD small molecules instruct the cell to degrade the target directly rather than activating or inhibiting the target protein function. As protein-protein interactions are involved in disease progression, removing the target protein provides a clear therapeutic advantage over simple inhibition. Specifically, Amphista’s platform is independent of traditional E3 ubiquitin ligases used by the field, potentially expanding the available target scope of TPD approaches and should overcome recently identified PROTAC® resistance mechanisms.

About Amphista Therapeutics
Amphista Therapeutics is a biopharmaceutical company creating first-in-class therapeutics that help harness the body’s natural processes to selectively and efficiently degrade and remove disease causing proteins. The company’s pipeline of novel small molecules that cause targeted protein degradation (TPD) is focused on challenging diseases including cancer. Amphista is a spin-out of renowned TPD expert Professor Alessio Ciulli’s labs at the University of Dundee, and is based in BioCity Glasgow, Scotland. The company is funded by leading life science investors including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and BioMotiv. For more information, visit http://www.amphista.com/

Filed Under: PR Tagged With: Cancer

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

2021 Was the Year of Container
AIML-powered trading is the future
DeFiRetailing.com (DeFi Retailing): DeFi will change retail as we know it
Wearable IoTs
Portuguese wine market is booming
Spending on Compute and Storage Infrastructure Grew Strongly Across Cloud and Non-Cloud IT Environments in the First Quarter of 2022, According to IDC
Critical Mineral Shortages Could Disrupt Global Supply Chains

Market Research Media

ESN.net, Event Sharing Network, Presents Upcoming Events
RealityCheckout.com (Reality Checkout): How do the past tech predictions fare?
Worldwide Public Cloud Services Revenues Grew 29.0% to $408.6 Billion in 2021, According to IDC
GruyereCheese.ch: Gruyere Cheese is Swiss
AIML.ag, AIML (Artificial Intelligence/Machine Learning)
TechnologyConference.com Presents Upcoming Events
NoSQLdatabase.com: SQL versus NoSQL overview

Secondary Sidebar

Technologies

Technologies could reduce 85–90% of GHG emissions in the EU
Cloudflare Unveils New SQL Database Offering
New Greentech Start-Up, Refhuel, to Develop Reversible Fuel Cell Technology
Ginkgo Bioworks has built the world’s largest DNA factory in a bid to alter the code behind life
Ceres and Shell announce electrolyser agreement for green hydrogen

Tech Events

Square to Hold Sixth Annual Unboxed Developers Conference on May 12, 2022
Enterprise Connect, September 27-29, 2021, Gaylord Palms hotel, Orlando, Florida
Tech Conference Line Developer Day 2021, November 10-11, 2021
The 2022 Design and Verification Conference and Exhibition United States (DVCon U.S.), February 28-March 3, 2022, Doubletree Hotel in San Jose, California
IEEE SERVICES 2021, the premier international computing and applications event, taking place 5-10 September 2021

Footer

Recent Posts

  • Plant-based food innovation company, TMRW Foods, raises C$2 million and prepares for North American launch with Sprouts Farmers Market
  • How to achieving gender balance in management teams
  • When you feel like you’re spiraling
  • After Successful Tax Season, Embedded Tax Platform April Raises $30M Series A from Fintech Veterans
  • Vita Mojo Raises US$30 Million to Help Restaurant and Hospitality Chains in Europe Tackle the Digital Future
  • Nautical Commerce Raises $30M to Scale Multi-Vendor Marketplace Technology
  • Token Announces $13 Million Series B Funding Round and Appointment of New CEO to Disrupt the Authentication Market
  • Konnecto Raises $21M to establish a new category in marketing technology
  • Sharebite, the Leading Food Benefits Platform, Announces Closing of $39 Million Series B Round
  • Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Dossier

Box Opens Research and Development Engineering Site in Warsaw, Polan
EVgo Added to Russell 3000® and Russell 2000® Indexes
iSpot Acquires Ace Metrix
Commerzbank and Google Cloud Strengthen Strategic Partnership
What were the top technology, media, and telecommunications (TMT) companies for total shareholder return (TSR)?

Press Media Release

ADL Says Buffalo Shooter Latest in A Long Line of White Supremacist Terrorists Who Embraced Racist, Antisemitic “Great Replacement Theory”
Texas A&M University System Regents Approve $70 million Engineering Building for Prairie View A&M University
Boeing to Highlight Sustainability, Technology and Partnerships at Singapore Airshow 2022
UNESCO: Culture of Ukrainian borscht cooking inscribed on the List of Intangible Cultural Heritage in Need of Urgent Safeguarding
Tanjo AI Launches New Enterprise Brain

App Coding

New app to help northeastern Illinois drivers avoid traffic and earn rewards for improving their commute
monday.com Adds Built-In Monetization Solution to the apps marketplace
Datadog Named a Leader in the 2022 Gartner® Magic Quadrant™ for Application Performance Monitoring and Observability
Ondat 2.8 Arrives in GA with Increased Support for Stateful Workloads in Kubernetes
Scrub your code in real-time

API Coding

Types of API Testing
Apiip Expand IP To Location API Services to Verify 1 million+ Requests A Month
What is a REST API?
WSO2 Completes $93 Million Series E Growth Funding Round with the Investment from Info Edge
API-based startup that connects African businesses

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT